Extracardiac Versus Lateral Tunnel Fontan: A Meta-Analysis of Long-Term Results.


Journal

The Annals of thoracic surgery
ISSN: 1552-6259
Titre abrégé: Ann Thorac Surg
Pays: Netherlands
ID NLM: 15030100R

Informations de publication

Date de publication:
03 2019
Historique:
received: 15 02 2018
revised: 20 07 2018
accepted: 20 08 2018
pubmed: 14 10 2018
medline: 8 11 2019
entrez: 14 10 2018
Statut: ppublish

Résumé

There is growing awareness of the long-term impact of a Fontan circulation on the associated morbidity and mortality. Comparative data on the incidence of supraventricular arrhythmia and sinus node dysfunction following extracardiac conduit (EC) and lateral tunnel (LT) Fontans are controversial. We performed a meta-analysis pooling all available long-term results comparing the EC and LT Fontan, with a special focus on arrhythmia. We performed a systematic search of PubMed, Embase, and the Cochrane Library for articles reporting long-term results of Fontan comparing the EC and the LT Fontan. Twelve studies were selected with 3,330 patients (1,729 EC, 1,601 LT). Freedom from tachyarrhythmia was significantly higher in the EC group (92% versus 83% at 15 years; p < 0.0001), while there was no difference in term of bradyarrhythmias (p = 0.7). The survival was 93% and 89% at 20 years in the EC and LT groups, respectively (p = 0.007). The risk of thromboembolic events was 2.87% patient-years in the EC group versus 0.9% in the LT group (odds ratio, 2.15; 95% confidence interval, 0.95 to 4.85; p = 0.07). The EC Fontan confers long-term survival advantage over the LT Fontan without a higher rate of reoperations. The EC Fontan preserves the sinus node function and reduces significantly the incidence of long-term postoperative arrhythmia.

Sections du résumé

BACKGROUND
There is growing awareness of the long-term impact of a Fontan circulation on the associated morbidity and mortality. Comparative data on the incidence of supraventricular arrhythmia and sinus node dysfunction following extracardiac conduit (EC) and lateral tunnel (LT) Fontans are controversial. We performed a meta-analysis pooling all available long-term results comparing the EC and LT Fontan, with a special focus on arrhythmia.
METHODS
We performed a systematic search of PubMed, Embase, and the Cochrane Library for articles reporting long-term results of Fontan comparing the EC and the LT Fontan.
RESULTS
Twelve studies were selected with 3,330 patients (1,729 EC, 1,601 LT). Freedom from tachyarrhythmia was significantly higher in the EC group (92% versus 83% at 15 years; p < 0.0001), while there was no difference in term of bradyarrhythmias (p = 0.7). The survival was 93% and 89% at 20 years in the EC and LT groups, respectively (p = 0.007). The risk of thromboembolic events was 2.87% patient-years in the EC group versus 0.9% in the LT group (odds ratio, 2.15; 95% confidence interval, 0.95 to 4.85; p = 0.07).
CONCLUSIONS
The EC Fontan confers long-term survival advantage over the LT Fontan without a higher rate of reoperations. The EC Fontan preserves the sinus node function and reduces significantly the incidence of long-term postoperative arrhythmia.

Identifiants

pubmed: 30315799
pii: S0003-4975(18)31442-5
doi: 10.1016/j.athoracsur.2018.08.041
pii:
doi:

Types de publication

Journal Article Meta-Analysis Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

837-843

Informations de copyright

Copyright © 2019 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Auteurs

Walid Ben Ali (W)

Division of Cardiac Surgery, CHU-ME Sainte Justine and the Montreal Heart Institute, Université de Montréal, Montréal, Canada.

Ismail Bouhout (I)

Division of Cardiac Surgery, CHU-ME Sainte Justine and the Montreal Heart Institute, Université de Montréal, Montréal, Canada.

Paul Khairy (P)

Division of Cardiac Surgery, CHU-ME Sainte Justine and the Montreal Heart Institute, Université de Montréal, Montréal, Canada.

Denis Bouchard (D)

Division of Cardiac Surgery, CHU-ME Sainte Justine and the Montreal Heart Institute, Université de Montréal, Montréal, Canada.

Nancy Poirier (N)

Division of Cardiac Surgery, CHU-ME Sainte Justine and the Montreal Heart Institute, Université de Montréal, Montréal, Canada. Electronic address: bouhout.ismail@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH